Mahsa Hajivalili

Reduction and exhausted features of T lymphocytes under serological changes, and prognostic factors in COVID-19 progression

Ata Mahmoodpoor, Maryam Hosseini, Mohammad Sadegh Soltani‐Zangbar et al. · Molecular Immunology · 2021 · 57 citations · Full text

Prognostic Factors, Covid-19 Progression, T-regulatory Cell +8

The anti-tumor effects of CT-26 derived exosomes enriched by MicroRNA-34a on murine model of colorectal cancer

Maryam Hosseini, Kaveh Baghaei, Mahsa Hajivalili et al. · Life Sciences · 2021 · 35 citations

Tumor Biology, Oncology, Medicine +9

Co-delivery of insulin-like growth factor 1 receptor specific siRNA and doxorubicin using chitosan-based nanoparticles enhanced anticancer efficacy in A549 lung cancer cell line

Hajar Shali, Mahdi Shabani, Fatemeh Pourgholi et al. · Artificial Cells Nanomedicine and Biotechnology · 2017 · 33 citations · Full text

Engineering, Biomedical Engineering, Igf-1r Sirna +16

G2013 modulates TLR4 signaling pathway in IRAK-1 and TARF-6 dependent and miR-146a independent manner.

Mahsa Hajivalili, Fatemeh Pourgholi, Jafar Majidi et al. · PubMed · 2016 · 29 citations

Application of newly developed SARS-CoV2 serology test along with real-time PCR for early detection in health care workers and on-time plasma donation

Mohammad Sadegh Soltani‐Zangbar, Leili Aghebati‐Maleki, Mahsa Hajivalili et al. · Gene Reports · 2021 · 20 citations · Full text

Point-of-care Testing, Viral Diagnostics, Medicine +9